Survey Suggests Industry Aversion To Facility Registration Fee
This article was originally published in The Gray Sheet
Executive Summary
More than 60% of 21 medical device firms surveyed last year opposed the idea of an FDA facility Registration fee as an alternative to premarket submission fees, according to a 1report issued May 23
You may also be interested in...
Postmarket User Fees Floated At House Subcommittee Hearing
The chairman of the House subcommittee overseeing reauthorization of medical device user fees is signaling that he might push to have a portion of industry-provided funds specifically allocated for FDA postmarket activities
MDUFMA Renewal Plan Spreads Fee Burden More Evenly; Senate Panel OKs
Just two days after FDA released its behind-schedule proposal to reauthorize the medical device user fee program, a Senate committee approved the agency's recommendations to collect almost $300 million from manufacturers through 2012
Industry Favors Predictability Over Speed In Next Round Of MDUFMA
Senior device industry staffers are more interested in improving the predictability of FDA's premarket review process than pushing the agency to accelerate its performance, an FDA 1report suggests